Suppr超能文献

人类天然抗Gal IgG。III。天然抗Gal与抗B抗体之间的交叉反应所证明的人类免疫耐受的微妙之处。

The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies.

作者信息

Galili U, Buehler J, Shohet S B, Macher B A

出版信息

J Exp Med. 1987 Mar 1;165(3):693-704. doi: 10.1084/jem.165.3.693.

Abstract

A well-defined antigen/antibody system was used to evaluate the effect of immune tolerance on the spectrum of specificities of natural antibodies. The antibody used in this study, anti-Gal, is a naturally occurring, polyclonal IgG that constitutes 1% of the circulating IgG in humans. We have previously shown that anti-Gal, purified from AB sera, specifically interacts with glycosphingolipids bearing a Gal alpha 1----3Gal epitope, but not with the closely related B antigen in which the penultimate galactose of the Gal alpha 1----3Gal epitope is fucosylated Gal alpha 1----3(Fuc alpha 1----2)Gal. This narrow specificity was assumed to be the result of an effective immune tolerance mechanism that prevents the expression of antibody clones that can recognize both the Gal alpha 1----3Gal and the self B epitopes. If the assumption that immune tolerance determines the range of anti-Gal specificity is correct, then anti-Gal from individuals lacking the B antigen (A and O blood types) would be expected to interact with both Gal alpha 1----3Gal and Gal alpha 1----3(Fuc alpha 1----2)Gal epitopes. In this study, anti-Gal from the serum of individuals of various blood types was purified by affinity chromatography on Gal alpha 1----3Gal adsorbent and tested for its reaction with the B antigen. Whereas anti-Gal from AB and B individuals only reacted with Gal alpha 1----3Gal epitopes, anti-Gal from A and O individuals reacted with both Gal alpha 1----3Gal and B epitopes. Furthermore, it was determined that the majority of anti-B reactivity in A and O individuals is in fact anti-Gal antibodies capable of recognizing both Gal alpha 1----3Gal and B epitopes. It can be concluded from these results that immune tolerance accurately controls the spectrum of natural antibody specificities by preventing the production of antibody clones that can interact with self antigens.

摘要

一个定义明确的抗原/抗体系统被用于评估免疫耐受对天然抗体特异性谱的影响。本研究中使用的抗体,抗Gal,是一种天然存在的多克隆IgG,占人类循环IgG的1%。我们之前已经表明,从AB血清中纯化的抗Gal,与带有Galα1----3Gal表位的糖鞘脂特异性相互作用,但不与密切相关的B抗原相互作用,在B抗原中,Galα1----3Gal表位的倒数第二个半乳糖被岩藻糖基化,即Galα1----3(Fucα1----2)Gal。这种狭窄的特异性被认为是一种有效的免疫耐受机制的结果,该机制阻止了能够识别Galα1----3Gal和自身B表位的抗体克隆的表达。如果免疫耐受决定抗Gal特异性范围的假设是正确的,那么来自缺乏B抗原(A和O血型)个体的抗Gal预计会与Galα1----3Gal和Galα1----3(Fucα1----2)Gal表位都相互作用。在本研究中,通过在Galα1----3Gal吸附剂上进行亲和层析,从各种血型个体的血清中纯化抗Gal,并测试其与B抗原的反应。而来自AB和B个体的抗Gal仅与Galα1----3Gal表位反应,来自A和O个体的抗Gal与Galα1----3Gal和B表位都反应。此外,还确定A和O个体中大多数抗B反应实际上是能够识别Galα1----3Gal和B表位的抗Gal抗体。从这些结果可以得出结论,免疫耐受通过阻止能够与自身抗原相互作用的抗体克隆的产生,准确地控制了天然抗体特异性的谱。

相似文献

引用本文的文献

4
The α-Gal epitope - the cause of a global allergic disease.α-半乳糖表位——一种全球过敏性疾病的病因。
Front Immunol. 2024 Jan 22;15:1335911. doi: 10.3389/fimmu.2024.1335911. eCollection 2024.
6
Genetic and structural basis of the human anti-α-galactosyl antibody response.人类抗α-半乳糖基抗体反应的遗传和结构基础。
Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2123212119. doi: 10.1073/pnas.2123212119. Epub 2022 Jul 8.
7
The α-Gal Syndrome and Potential Mechanisms.α-半乳糖综合征及其潜在机制。
Front Allergy. 2021 Dec 16;2:783279. doi: 10.3389/falgy.2021.783279. eCollection 2021.
8
"Mysterious veil" between the blood group system and pathogens.血型系统与病原体之间的“神秘面纱”。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Oct 28;46(10):1159-1166. doi: 10.11817/j.issn.1672-7347.2021.200659.

本文引用的文献

3
The somatic generation of immune recognition.免疫识别的体细胞产生
Eur J Immunol. 1971 Jan;1(1):1-9. doi: 10.1002/eji.1830010102.
4
HUMAN A- AND B-LIKE ANTIGENS ON RED CELLS OF MARMOSETS.狨猴红细胞上的人A和B样抗原。
Proc Soc Exp Biol Med. 1964 Dec;117:858-61. doi: 10.3181/00379727-117-29718.
8
Blood-group substances.血型物质
Science. 1966 Apr 8;152(3719):172-81. doi: 10.1126/science.152.3719.172.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验